Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mondae vs OurView Health

By GLP-1 ScorecardUpdated

MondaeFactor scores not reassessed.
Site position #69

Higher score

OurView HealthFactor scores not reassessed.
Site position #175

Lower score

Score comparison

Mondae has the higher recorded score — 74.3/100 to 67.6/100.

Mondae grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mondae shows one-, three- and six-month prices for both compounded injections. Get the payment schedule and refund terms before choosing a longer plan.

Before you choose

Before comparing the headline prices, the Mondae review and the OurView Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Mondae vs Potere Health MD and OrderlyMeds vs OurView Health compare each of them with another graded program, and the list of alternatives to Mondae ranks the programs closest to Mondae on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the MyDrHank review covers one graded close to these two, at 68.2/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueMondae +14
90
76
Dose & formulationEven
64
64
Clinical oversightOurView Health +7
72
79
Labs & monitoringOurView Health +1
52
53
FulfillmentMondae +19
89
70
Contract termsMondae +32
77
45
Mondae · top barOurView Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricMondaeOurView Health
WeighScore74.3/10067.6/100
GradeCC
Site position#69#175
Semaglutide$87 for 1 month (compounded; confirm billing interval)$75/mo (starting dose, compounded)
Tirzepatide$126 for 1 month (compounded; confirm billing interval)$135/mo (starting dose, compounded)
CoverageConfirm treatment availability in your stateCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Mondae

Site position #69 · C

Factor scores not reassessed.

Strengths

  • Both product pages show one-month prices and display totals for longer plans
  • The product pages advertise the same price across doses and no membership fee
  • The terms describe a prorated refund for unshipped supply when the prescribed treatment cannot be fulfilled

What to consider

  • The lowest monthly figures are six-month equivalents; the product pages do not confirm the selected debit schedule
  • The refund policy describes nonrefundable consultation fees and restricts prescription cancellations after dispensing or shipping
  • The two GLP-1 product pages do not establish the dispensing pharmacy for a selected order
OurView Health

Site position #175 · C

Factor scores not reassessed.

Strengths

  • Low starting prices via the Savings Club — compounded semaglutide from $75, tirzepatide from $135
  • Clear product pricing with no contracts; medication shipped to your door (30-day supply)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
  • Discloses meds are compounded by a licensed third-party pharmacy; multi-vertical (TRT, HRT, BHRT, peptides)

What to consider

  • A comparison table on the site quotes $90 'without membership' against $75 'with membership' while the product cards say 'No membership' and the cart charges $75 without one — the provider contradicts itself on whether a membership exists
  • Both figures are starting-dose rates; the cost of a titrated dose is published as a ladder rather than a single price
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard